Brief: International Stem Cell Corp posts positive interim clinical results for Parkinson's disease clinical trial
13/11/2017 13:30
Nov 13 (Reuters) - International Stem Cell Corp ISCO.PK
* International Stem Cell Corporation announces positive
interim
clinical results for Parkinson's disease clinical trial
* International Stem Cell Corp - all patients in first
cohort
receiving 30 million ISC-hpNSC cells are currently meeting
primary endpoint, which is safety
Source text for Eikon: ID:nMKWqtp0na
Further company coverage: ISCO.PK
((bangalore.newsroom@thomsonreuters.com;))
Recent news on International Stem Cell
See all newsBayer says Parkinson's stem cell therapy improves symptoms in initial trial
Brief: International Stem Cell Corp posts positive interim clinical results for Parkinson's disease clinical trial
Brief: International Stem Cell to expand its revenue generating biomedical businesses
Brief: International Stem Cell receives approval to start second patient cohort in clinical trial for Parkinson's disease
Brief: International Stem Cell Q3 revenue falls 9 pct to $1.94 mln